ABSTRACT To assess the quantitative relation between exposure to airborne cadmium and various markers ofrenal tubular and glomerular function, 45 male workers employed at a plant that recovers cadmium from industrial waste and 32 male hospital workers ofsimilar age and geographical location were examined. Cumulative external exposure to airborne cadmium (dose) was estimated from historical air sampling data, adjusted for respirator use. Increasing cadmium dose was associated with multiple renal tubular functional abnormalities, including reduced reabsorption of beta-2-microglobulin (f,-2), retinol binding protein (RBP), calcium, and phosphate. Serum creatinine concentration also increased with cadmium dose, suggesting impaired glomerular function. Mean systolic and diastolic blood pressures were higher in the cadmium workers than in the unexposed (134 v 120 mm Hg and 80 v 73 mm Hg respectively), but only systolic blood pressure was significantly associated with cadmium dose in multivariate analyses. Cadmium dose remained the most i-mportant predictor of serum creatinine concentration after controlling for age, blood pressure, body size, and other extraneous factors. Logistic regression to model the probability (prevalence) of various renal abnormalities with increasing dose of cadmium was used. The probability of multiple tubular abnormalities and raised serum creatinine concentration increased sharply at cumulative cadmium exposures exceeding 300 mg/m3 days, corresponding to working for 4-3 years at the current permissible United States exposure limit for cadmium dust.
States are exposed occupationally.2 A much larger population is exposed either by living in the vicinity of non-ferrous smelters or by consuming food or tobacco grown on contaminated soil.' Chronic cadmium poisoning is known to cause an acquired Fanconi syndrome, a constellation of aminoaciduria, low molecular weight proteinuria, glycosuria, phosphate wasting, and altered calcium metabolism.3 The diagnosis of cadmium nephropathy is usually made presumptively by documenting increased urinary excretion of small proteins such as beta-2-microglobulin (f,-2) and retinol binding protein (RBP) in subjects with known exposure to cadmium. Accepted 28 November 1988 Although the tubular effects of cadmium are well recognised, controversy exists about the dose of cadmium at which nephropathy appears and about the significance of P-2 and other renal tubular abnormalities in predicting progressive loss of glomerular function. The relation between cadmium and conditions related to kidney function such as hypertension, kidney stones, and altered calcium phosphorous metabolism also remains controversial.
To assess the quantitative relation between exposure to cadmium, various markers of renal tubular and glomerular dysfunction, and disorders potentially related to cadmium and nephropathy, we examined workers exposed to cadmium at a metal recovery plant in Colorado. The population is unique in that airbome exposures to cadmium were extremely high in the past, the workforce is stable, and concentrations of airborne cadmium have been measured regularly in nearly all departments since the 1940s. 689 690 Background Since 1925 the plant has recovered cadmium from "bag house" dust, a byproduct of non-ferrous smelting. The details of the process Logistic regression was used to determine the probability of renal outcomes being "abnormal" at various exposure levels, when abnormal was defined by the geometric mean in the unexposed minus two SDs (for %TRC and %TRP) or plus two SDs (for /-2, RBP, and creatinine).
Results
Forty five cadmium workers and 32 unexposed hospital workers took part in the study. Participation among current cadmium production workers was 17/19 (89%) and among highly exposed former workers 18/27 (67%). Two salaried workers and eight former short term production workers not in the target population also took part. Reasons offered for nonparticipation were illness (4), desire not to offend the company (2), exposure too long ago (1), and unspecified (4). Non-exposed hospital workers were initially recruited from the maintenance department (12) and shipping and food service (7) . Older unexposed subjects were subsequently recruited from office workers (6) and professionals (7).
We observed several demographic differences between the cadmium exposed and comparison populations (table 2). The cadmium workers were slightly older (mean age 54 v 50, p = 0-2) and more likely to be Hispanic (58% v 16%, p < 0 0001). The exposed workers were shorter and heavier than the unexposed, resulting in a significantly higher mean Quetelet index (29-5 v 26-3, p = 0-001). Fewer of the cadmium workers were current smokers (38% v 44%, p = 0 6) and of those who had ever smoked, they had consumed fewer pack-years on average (14-6 v 22-1,
Measures ofexposure to cadmium and lead are also included in table 2. Blood cadmium concentrations were significantly higher in the exposed workers than in the unexposed (7-9 v 12 pg/l, p < 0 0001), as was urine cadmium (9 3 v 0 7 ug/g creatinine, p < 0 0001). The average blood lead concentration was higher in the cadmium workers than in the unexposed (11-9 v 8-3 pg/l, p = 0-0013). The highest current blood lead concentration was 32-6 pg/l. Excretion of,-2 is highly correlated with other indices of kidney dysfunction. Correlation coefficients between P-2 (yg/g creatinine) and other markers are as follows: RBP (R = 0-91, p < 0-0001), %TRP (R = -0-63, p < 0-0001), %TRC (R = -0 53, p < 0.0001), and serum creatinine (R = 0-51, p < 0o0001).
Clinically significant abnormalities are clustered in the ten cadmium workers whose urinary ,B-2 excretion exceeds 1000 pg/g creatinine. For example, three of these have serum creatinine 2 1-8 mg/dl, four have serum phosphorous below 2-5 mg/dl, and four have %TRP <65%, whereas none of the 32 unexposed workers had similar abnormalities. Mildly raised serum alkaline phosphatase (> 170 International Units) was measured in three of the 10 cadmium workers with the highest P-2 versus one of the 32 unexposed. A detailed clinical presentation of the metabolic abnormalities will be presented elsewhere. (1.7) (0-005-0-05) 0-0012 Calcium:
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(1.03) cadmium concentration. We also included age, systolic and diastolic blood pressure, Hispanic ethnicity, months since last exposure to cadmium, Quetelet index, body surface area, history of hypertension, prostatic disease, and diabetes, and blood lead concentration. Figure 2 shows the data points, regression line, and 95% upper and lower confidence intervals for the models best explaining f-2, RBP, %TRC, %TRP, and serum creatinine concentration. Table 4 Time since last exposure to cadmium was not an important determinant of any renal outcome, either by itself or as a modifier of cadmium dose. Most of the workers with high f-2 excretion had not been exposed for several years. For example, nine of the 15 (60%) cadmium workers with the highest f-2 excretion had not been exposed to cadmium for at least five years, and one for 45 years.
We looked particularly closely at whether the higher serum creatinine concentrations in the cadmium workers might be explained by a known risk factor such as age, diabetes, prostatic disease, or hypertension rather than cadmium. The relation between cadmium dose and serum creatinine concentration persisted even when we excluded from the analysis all those with current diastolic blood pressure > 90 mm Hg, systolic pressure > 150 mm Hg, or positive history of diabetes, prostatic disease, or hypertension, while controlling for age, ethnicity, and blood lead concentration (coefficient for dose x 10-4 = 0-476, p = 0-0007). We also tested whether kidney stones might provide a mechanism linking cadmium to increasing serum creatinine concentrations by excluding subjects with kidney stones from the regression analysis. The coefficient for dose To test whether extreme or outlying data points might distort the slope of any of these regression lines, we repeated the analyses in table 3 after excluding the most extreme outliers. Outliers were excluded if the residual (observed value-predicted value) exceeded the 95th percentile. Exclusion of outliers had a negligible effect on the coefficient for dose for any of the renal endpoints. In all cases the F value for dose remains highly significant. In the absence of a cogent reason to exclude the outliers we present the full data. Table 4 and fig 2 do not show the relation between cadmium dose, systolic or diastolic blood pressure, or albuminuria. Dose is a statistically significant predictor of systolic but not of diastolic blood pressure, after controlling for age, Quetelet index, ethnicity, and blood lead concentration. As dose increases from 0 to 5000 mg/m3 days, mean predicted systolic blood pressure increases from 125-9 to 145-3 mm Hg (log SBP = 2-10 + 0-1246 x dose x 10-4, p = 0 04). Dose is also a statistically significant predictor of the urinary albumin/creatinine ratio, as are age and systolic blood pressure. We do not present this model because of space limitations and because the relation of albuminuria to dose does not clarify whether the urinary albumin reflects a pure tubular or a mixed tubular and glomerular lesion. Figure 3 illustrates the probability of having various 694 I :.
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group renal abnormalities versus cumulative exposure to cadmium. The definitions of "abnormal" are specified in the legend for figure 3 and are defined based on the unexposed workers. 
Discussion
The cross sectional data presented here help to quantify the relation between exposure to cadmium and several parameters of renal tubular and glomerular dysfunction. Increased cumulative exposure to cadmium (dose) is accompanied by increased low and high molecular weight proteinuria, reduced calcium and phosphorous reabsorption, and rising serum creatinine concentration. While these data are cross sectional rather than longitudinal, they provide an important link in the theoretical continuum bet- 696 ween the subacute renal toxicity and more serious long term sequelae of cadmium exposure.
The extensive numbers of reports on cadmium nephropathy suggest that at least two manifestations of renal dysfunction may be of particular clinical and public health importance. Firstly, disturbed calcium phosphorous metabolism, manifest in our study by phosphaturia, low serum phosphorous, and low tubular reabsorption of calcium are postulated to contribute to the bone disease and kidney stone formation observed in certain groups exposed to cadmium.318 Secondly, progressive loss of renal tubular function may cause, or be accompanied by, a more subtle reduction in GFR and increased serum creatinine. 3 An epidemic of severe bone disease occurred in Japan among women consuming rice contaminated with cadmium.'819 The syndrome was called Itai itai (ouch ouch) disease, and was manifest by bone pain, skeletal deformities, and spontaneous fractures. Even in villages where rice was heavily contaminated with cadmium, clinical osteopathy was confined to poorly nourished, postmenopausal women, suggesting that cadmium precipitated clinical disease in those at high risk due to nutritional and endocrinologic factors.'819 Similar bone disease has been rare in occupational populations. Bone pain and spontaneous fractures were reported in British and French alkaline battery workers near the end of the second world war.'820 In general, however, male workers with adequate nutrition do not experience spontaneous fractures or radiological abnormalities and female workers have not been studied longitudinally for the occurrence of osteopathy after menopause.
A second potential consequence of hypercalcuria or phosphaturia is susceptibility to kidney stones. Kidney stones are common in cadmium exposed populations, with lifetime prevalence reportedly ranging from 19% to 44%.3 In our study eight (18%) of the 45 cadmium workers had experienced kidney stones versus one (3%) of the 32 unexposed. Several mechanisms could link stone formation to renal tubular disease, including hypercalcuria, phosphaturia, uricaciduria, reduced urinary citrate, or renal tubular acidosis.2" The field techniques used in our study did demonstrate differences in calcium and phosphorous excretion associated with the cadmium workers but were not designed to be a complete clinical or metabolic evaluation. Future research should attempt to characterise the urinary composition of cadmium workers in a more controlled clinical setting.
Field investigators have generally been unable to study the effects of cadmium on glomerular filtration rate (GFR). Friberg, in Scandinavia, measured insulin clearance in 19 heavily exposed alkaline battery workers. GFR was below population normals in these Thun, Osorio, Schober, Hannon, Lewis, Halperin workers but the study could not control for age or relate inulin clearance to quantified exposure levels.21
Adams found increased serum creatinine concentration in nearly all of 23 workers with severe tubular proteinuria.23 Our study is unique in relating increasing serum creatinine concentration to quantified dose of cadmium. It is also the first to use multivariate techniques to determine that cadmium, rather than age, hypertension, or other extraneous variables best explains this relation. Although serum creatinine concentration is less sensitive than creatinine or inulin clearance as a measure ofGFR, using serum creatinine concentration as the marker of glomerular function is more likely to obscure a true association with cadmium than to create a false positive one. The theoretical possibility exists that cadmium might increase serum creatinine concentration by a tubular mechanism, selectively decreasing postglomerular secretion of creatinine by the nephron while sparing tubular reabsorption. Such an explanation is unsupported by experimental studies of cadmium.
Evidence of tubular dysfunction persists in some workers in our study for decades after the cessation of exposure to cadmium. Other investigators have noted that fi-2 persists and even increases in some workers after employment ceases.3 The issue ofthe reversibility of nephropathy is controversial, however, partly because longitudinal data are rarely available and partly because the assay for -2 has increased in sensitivity over time. In our study multiple tubular lesions were manifest in workers who had retired many years before. Furthermore, in multiple regression analyses time away from cadmium did not appear to modify the association between cadmium dose and any renal endpoint. These data suggest that if cadmium nephropathy is reversible the recovery is so slow as to be undiscernable in our data set.
The significantly higher systolic and diastolic blood pressure in the cadmium workers, relative to the unexposed, is an interesting and a potentially important finding. It resurrects a longstanding debate about whether cadmium can cause hypertension in man. Hypertension has been observed experimentally in rats drinking cadmium contaminated water.24 It has been sought for but rarely found in studies of highly exposed workers. 25 A theory has been advanced that low doses of cadmium may increase, and higher doses may decrease, blood pressure in man. 25 Blood pressure measurements in our study were performed by a single examiner using one instrument. We did not expect an association between blood pressure and cadmium. Rather we measured blood pressure as a factor to be controlled in the analysis of serum creatinine concentration. Neither hypertension by history nor current blood pressure explained the relation between exposure to cadmium and serum creatinine concentra-
